FY2022 · ended Dec 31, 2022 · Revenue $249,040 · Filed Mar 28, 2024
Bluejay Diagnostics, Inc. (BJDX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$6.2 million. As of Jun 30, 2026 it held $9.6 million in cash and investments and $80,670 in total debt.
Revenue
$249,040
Net income
$-6.85M
+11.3% vs prior year
Operating cash flow (TTM)
$-5.90M
+13.8% vs year-ago TTM
Free cash flow (TTM)
$-5.93M
EPS
$-15.25
+96.7% vs prior year
Dividend per share
None
Shares outstanding
972,215
-34.9% vs prior year
Net cash
$9.52M
as of Jun 30, 2026
Operating margin
-3741.5%
FY 2022
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BJDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1704287
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $249,040 | — |
| Operating income | -$7.0M | -$7.2M | -$10.3M | -$9.3M | -$3.2M |
| Net income | -$6.8M | -$7.7M | -$10.0M | -$9.3M | -$3.5M |
| Diluted EPS | -$15.25 | -$456.75 | -$3,631.48 | -$9.22 | — |
| Operating cash flow | -$6.1M | -$7.8M | -$8.3M | -$7.7M | -$4.4M |
| Free cash flow | -$6.2M | -$8.1M | -$9.0M | -$8.9M | -$4.4M |
| Total assets | $7.1M | $6.7M | $4.9M | $13.5M | $21.0M |
| Total liabilities | $1.1M | $927,924 | $2.0M | $2.0M | $637,162 |
| Stockholders' equity | $6.0M | $5.7M | $2.9M | $11.5M | $20.4M |
| Cash and investments | $5.2M | $4.3M | $2.2M | $10.1M | $19.0M |
| Total debt | $129,558 | $235,623 | $370,105 | $492,621 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
All 249 Bluejay Diagnostics, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.